BIOTECHNOLOGY-PHARMA-CHEMICAL COMPANIES IN EUROPE
BIOTECHNOLOGY-PHARMA-CHEMICAL WORLD COMPANIES
ON BIOTECHNOLOGY EUROPE
05.06.2008 Novel Investigational Regimen Combining Radiation Enhancing Agent With Ibritumomab Tiuxetan (Zevalin(R)) Produces High Rate of Complete Responses in Patients With Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma
05.06.2008 Merck Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
02.06.2008 MediGene Focuses its Strategy on Oncology and Immunology